文献速递传染病防控与疫情报告免疫规划

男男性行为者脑膜炎球菌病监测——美国,2015-2016年

Meningococcal Disease Surveillance in Men Who Have Sex with Men - United States, 2015-2016.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2018-09-28

2015-2016年,美国45个州强化监测报告271例≥18岁男性脑膜炎球菌病,其中48例(17.7%)为MSM,MSM中39例(84.8%)由C群引起,而非MSM中仅16.4%由C群引起;MSM中17例(37.8%)合并HIV感染。MSM可能仍被低估,需改进监测数据以了解其患病与风险并指导政策和预防策略。

要点

  • MSM占男性脑膜炎球菌病病例的17.7%(48/271),其中37.8%(17/48)合并HIV感染。
  • MSM病例中C群占84.8%(39/48),非MSM病例中C群仅占16.4%。
  • 推荐MSM暴发控制使用四价脑膜炎球菌结合疫苗(MenACWY),≥2月龄HIV感染者应接种。

核心结论

  • MSM在男性脑膜炎球菌病患者中可能仍被低估,需改进监测数据以了解MSM中脑膜炎球菌病的患病率和风险,并为政策和预防策略提供信息。

研究设计与样本

  • 基于2015-2016年美国45个州参与强化脑膜炎球菌病监测的≥18岁男性病例报告,收集补充数据和分离株。

主要发现

  • 2015-2016年共同45个州向NNDSS报告271例≥18岁男性脑膜炎球菌病病例。
  • 48例(17.7%)为MSM,其中17例(37.8%)合并HIV感染。
  • MSM中39例(84.8%)由C群脑膜炎奈瑟菌引起,非MSM中C群仅占16.4%。

关键数值与推荐

  • 推荐使用四价脑膜炎球菌结合疫苗(MenACWY)控制由A、C、W或Y群引起的脑膜炎球菌病暴发,包括MSM中的暴发。
  • 所有≥2月龄HIV感染者应接种MenACWY疫苗,因其脑膜炎球菌病风险增加。

临床怎么用

  • MSM暴发控制推荐使用MenACWY疫苗。
  • 所有≥2月龄HIV感染者应接种MenACWY疫苗。

局限性

  • MSM在脑膜炎球菌病男性患者中可能仍被低估。
  • 需改进监测数据以了解MSM中脑膜炎球菌病的患病率和风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Meningococcal disease is a rare, but serious, bacterial infection that progresses rapidly and can be life-threatening, even with prompt antibiotic treatment. Men who have sex with men (MSM) have previously been reported to be at increased risk for meningococcal disease compared with other men, and recent outbreaks of serogroup C meningococcal disease among MSM have occurred (1). However, the epidemiology of meningococcal disease among MSM in the United States is not well described, in part, because information about MSM has not historically been collected as part of routine meningococcal disease surveillance. To better characterize and identify risk factors for meningococcal disease in general, supplementary data and isolates have been collected since 2015 through enhanced meningococcal disease surveillance activities. During 2015-2016, 271 cases of meningococcal disease in men aged ≥18 years were reported to the National Notifiable Diseases Surveillance System (NNDSS) in 45 states participating in this enhanced surveillance. Forty-eight (17.7%) cases were in men identified as MSM, including 17 (37.8%) with human immunodeficiency virus (HIV) infection. Among MSM, 39 (84.8%) cases were caused by Neisseria meningitidis serogroup C, whereas this serogroup was responsible for only 16.4% of cases among men who were not known to be MSM (non-MSM). Despite improvements in surveillance, MSM likely remain underascertained among men with meningococcal disease. Improved surveillance data are needed to understand the prevalence of and risk for meningococcal disease among MSM and inform policy and prevention strategies. Vaccination with quadrivalent meningococcal conjugate (MenACWY) vaccine is recommended for the control of meningococcal disease outbreaks caused by serogroups A, C, W, or Y, including during outbreaks among MSM; in addition, all persons aged ≥2 months with HIV infection should receive MenACWY vaccine because of the increased risk for meningococcal disease.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Bozio CH, Blain A, MacNeil J, et al. Meningococcal Disease Surveillance in Men Who Have Sex with Men - United States, 2015-2016. MMWR Morb Mortal Wkly Rep. 2018. PMID: 30260947. doi:10.15585/mmwr.mm6738a4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。